[Adiposity-related anthropometric parameters, indoles and atherosclerotic cardiovascular disease in Chinese adults: a prospective cohort study].

<b>Objective:</b> To investigate the relationship of several adiposity-related anthropometric parameters, including BMI, waist circumference (WC), waist-to-hip ratio (WHR), body fat percentage (BFP) and indoles in plasma with the incidence of atherosclerotic cardiovascular disease (ASCVD) in adults in China. <b>Methods:</b> In China Kadoorie Biobank (CKB) study, blood samples were collected from 2 183 participants in the first resurvey in 2008 to detect indoles. Participants' body weight, body height, WC, hip circumference, and BFP were measured at baseline survey in 2004 and resurvey in 2008, the BMI and WHR were calculated with standardized methods. The long-term follow-up of all participants started from the completion of the resurvey in 2008 until the occurrence of incident ASCVD, death, loss to follow-up or until December 31, 2018. CKB ascertained outcome status (incident ASCVD) through death and disease registries and national health insurance databases, supplemented by active follow-up. Multivariate linear regression model was used to estimate the associations of anthropometric measurements at baseline survey and the first resurvey, and changes in these measurements with 3 indoles [indole, indole-3-acetic acid (IAA), and indole-3-propionic acid (IPA)]. Cox proportional hazard regression model was used to estimate the associations between indoles and the risk for ASCVD. <b>Results:</b> Anthropometric measurements at baseline survey or the first resurvey were negatively associated with plasma IPA level. The regression coefficient (<i>β</i>) of baseline BMI (per 1.0 kg/m²) with 0.1 standard deviation (<i>SD</i>) IPA was -0.23 (95%<i>CI</i>: -0.36 - -0.10) (false discovery rate=0.004). After adjusting for baseline BMI, the <i>β</i> of baseline WC, WHR and BFP with 0.1 <i>SD</i> IPA were -0.09 (95%<i>CI</i>: -0.18 - -0.01), -0.12 (95%<i>CI</i>: -0.19 - -0.05), and -0.20 (95%<i>CI</i>: -0.32 - -0.08), respectively. The annual change in BMI (difference between BMI in 2008 and 2004 divided by the time interval) was associated with indole and IAA, with <i>β</i> of 1.40 (95%<i>CI</i>: 0.58 - 2.21) and -1.07 (95%<i>CI</i>: -1.91 - -0.23), respectively, at each 0.1 increase of <i>SD</i>. Over a median (<i>Q</i>₁, <i>Q</i>₃) follow-up of 10.46 (10.36, 10.53) years after 2008 resurvey, 236 cases of ASCVD were recorded. IAA and IPA levels were negatively associated with the risk for ASCVD, with hazard ratios for one <i>SD</i> increase of IAA and IPA of 0.87 (95%<i>CI</i>: 0.76 - 0.99) and 0.84 (95%<i>CI</i>: 0.73 - 0.96), respectively. <b>Conclusions:</b> Our results suggested that anthropometric measurements and their changing trends affect the levels of plasma imicrobial tryptophan metabolite levels, decreased levels of IAA and IPA levels are associated with increased risk of ASCVD and indoles in plasma including IPA and IAA might be the mediating factors for adiposity-induced ASCVD.